English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
 
 
DownloadE-Mail
  Oligonucleotide-protamine-albumin nanoparticles: preparation, physical properties, and intracellular distribution

Vogel, V., Lochmann, D., Weyermann, J., Mayer, G., Tziatzios, C., van den Broek, J. A., et al. (2005). Oligonucleotide-protamine-albumin nanoparticles: preparation, physical properties, and intracellular distribution. Journal of Controlled Release, 103(1), 99-111. doi:10.1016/j.jconrel.2004.11.029.

Item is

Files

show Files

Locators

show

Creators

show
hide
 Creators:
Vogel, Vitali1, Author
Lochmann, Dirk2, Author
Weyermann, Jörg2, Author
Mayer, Gottfried1, Author
Tziatzios, Christos1, Author
van den Broek, Jacomina A.1, Author
Haase, Winfried3, Author           
Wouters, Daan4, Author
Schubert, Ulrich S.4, Author
Kreuter, Jörg2, Author
Zimmer, Andreas5, Author
Schubert, Dieter1, Author
Affiliations:
1Institut für Biophysik, Johann Wolfgang Goethe-Universität, 60590 Frankfurt am Main, Germany, ou_persistent22              
2Institut für Pharmazeutische Technologie, Johann Wolfgang Goethe-Universität, 60439 Frankfurt am Main, Germany, ou_persistent22              
3Department of Structural Biology, Max Planck Institute of Biophysics, Max Planck Society, ou_2068291              
4Laboratory of Macromolecular Chemistry and Nanoscience, Eindhoven University of Technology, NL-5600 MB Eindhoven, The Netherlands, ou_persistent22              
5Institut für Pharmazeutische Chemie und Pharmazeutische Technologie, Karl-Franzens-Universität, 8010 Graz, Austria, ou_persistent22              

Content

show
hide
Free keywords: Nanoparticles; Phosphorothioates; Protamine; Human serum albumin (HSA); Cellular release
 Abstract: Oligodesoxynucleotides (ODNs) or the corresponding phosphorothioates (PTOs) spontaneously form spherical nanoparticles (“proticles”) with protamine in aqueous solutions. The proticles can cross cellular membranes and release the ODNs within the cells. Thus, they represent a potential drug delivery system. The major disadvantages of this system are a lack of stability in salt solutions and its inability to also release PTOs. The present study shows, using PTOs and protamine free base, that these shortcomings can be eliminated by the addition of human serum albumin (HSA) as a third component to the starting mixture. The “ternary” proticles thus obtained contain maximally a few percent of the HSA that was originally present. Nevertheless, they differ from the previously studied “binary” proticles: (1) They are stable in salt solutions for at least several hours. (2) They show a high cellular uptake into murine fibroblasts, and they readily release the PTOs after uptake. The ternary proticles therefore represent a considerable improvement over binary proticles for use as drug delivery systems.

Details

show
hide
Language(s): eng - English
 Dates: 2004-07-162004-11-222005-01-082005-03-02
 Publication Status: Issued
 Pages: 13
 Publishing info: -
 Table of Contents: -
 Rev. Type: Peer
 Identifiers: DOI: 10.1016/j.jconrel.2004.11.029
PMID: 15710504
 Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show
hide
Title: Journal of Controlled Release
Source Genre: Journal
 Creator(s):
Affiliations:
Publ. Info: Amsterdam : Elsevier
Pages: - Volume / Issue: 103 (1) Sequence Number: - Start / End Page: 99 - 111 Identifier: ISSN: 0168-3659
CoNE: https://pure.mpg.de/cone/journals/resource/954925484703